EQS-News: Marinomed Biotech AG / Key word: Preliminary Results
Marinomed Biotech AG announces preliminary revenue for 2023
14.02.2024 / 07:45 CET/CEST
The issuer is.
EQS-News: Marinomed Biotech AG with important progress for Carragelose in 2024 finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.
EQS-News: Marinomed Biotech AG / Key word: Study/Patent
Marinomed Biotech AG with important progress for Carragelose in 2024
07.02.2024 / 07:45 CET/CEST
The issuer is.